Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
INBX · against 471 other Healthcare companies of similar size
Ranked #459 of 472 · scores higher than 3% of peers · safety percentile 4
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)41 peers with a safety percentile of 0–9, including INBX · Click a bar to see the companies
Mainly because of its beta and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | INBX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 445 reported | Not reported | 0.20× | — | — | 33% |
| BetaLower is better · 445 reported | 3.82 | 0.48 | 0% | 33% | |
| Current ratioHigher is better · 458 reported | 5.07× | 2.88× | 73% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 1.2B USD | 99 | ||
| 455 | 1.4B USD | 4 | ||
| 456 | 15.7B SEK (≈$1.6B) | 4 | 51 | |
| 457 | 1.2B USD | 4 | 24 | |
| 458 | 684M USD | 4 | ||
| 459 | 1.2B USD | 4 | 6 | |
| 460 | 758M USD | 4 | 35 | |
| 461 | 2.4B USD | 3 | 6 | |
| 462 | 1.2B CHF (≈$1.4B) | 2 | 34 | |
| 463 | 825M USD | 2 | 24 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score